corporate_finance

Johnson Controls Declares $0.40 Quarterly Dividend, Payable Oct. 16

Image
Johnson Controls Declares $0.40 Quarterly Dividend, Payable Oct. 16

Cork, Ireland – September 13, 2026 -- Johnson Controls International plc (NYSE: JCI) has approved a regular quarterly dividend of $0.40 per share of common stock, the board announced.

Board sets Oct. 16, 2026 payout date for shareholders of record

The dividend is payable on Oct. 16, 2026, to shareholders of record as of the close of business on Sept. 21, 2026.

Company extends 139-year unbroken dividend streak

Johnson Controls has paid a consecutive dividend since 1887, a track record spanning through multiple economic cycles. The Cork, Ireland-based firm operates in thermal management, mission-critical building systems, energy efficiency and decarbonization, serving sectors including data centers, healthcare, pharmaceuticals, advanced manufacturing and higher education.

Ericsson Buys Back Shares Under SEK 15 Billion Program

Stockholm – September 09, 2026 -- Telefonaktiebolaget LM Ericsson repurchased Class B shares between August 31 and September 4, 2026, lifting its treasury stock holding to 105,668,676 Class B shares.

Ericsson executes buybacks under a SEK 15 billion program launched in April 2026

The transactions form part of a share buyback program of up to SEK 15,000,000,000 that Ericsson announced on April 16, 2026. The program runs from April 23, 2026, through March 31, 2027, at the latest, and is being carried out on Nasdaq Stockholm by Goldman Sachs Bank Europe SE on Ericsson's behalf.

Board plans to propose cancellation of repurchased shares at 2027 AGM

Ericsson's Board of Directors intends to propose to the 2027 Annual General Meeting that the repurchased shares be cancelled, except for those retained to fulfil obligations under the company's share-related incentive programs.

Inturai Ventures Closes Private Placement, Raises $963,713.70

Image
Inturai Ventures Closes Private Placement, Raises $963,713.70

Vancouver – September 09, 2026 -- Inturai Ventures Corp. (CSE: URAI) (OTC: URAIF) (FSE: 3QG0) has closed the final tranche of its non-brokered private placement, bringing total gross proceeds from the offering to $963,713.70.

Final tranche adds $22,714.05 to funding round

The company issued 151,427 Units at $0.15 per Unit in the second and final tranche, completing an offering that in aggregate saw 6,424,758 Units sold since inception.

Each unit pairs a share with a two-year warrant priced at $0.25

Every Unit comprises one common share and one warrant, with the warrant exercisable for 24 months at $0.25 per share. The warrants carry an accelerated expiry clause: if Inturai's share price closes at or above $0.35 for five consecutive trading days, the company can trigger a 30-day exercise window before expiry.

Dimerix Secures A$34M Non-Dilutive Loan to Fund Kidney Disease Trials

Melbourne – September 08, 2026 -- Dimerix Limited (ASX: DXB) has secured non-dilutive loan facility agreements worth up to A$34 million with a syndicate of Australian and U.S. lenders, expanding on its previously announced A$10 million SKIPTAN facility.

Dimerix locks in A$34 million loan facility from Australian, U.S. lenders

The new terms are substantially consistent with the earlier SKIPTAN agreement, with minor amendments made to standardise conditions across all lenders. The structure gives Dimerix the option to expand total commitments to A$50 million on or before March 31, 2027, though the company currently has no plans to draw on that additional capacity.